Desq Long
Sign in
SEC FORM 4
—

NewAmsterdam Pharma Co N.V. (NAMS)

Acquisition (code M) of 50,246 shares; price not stated (see filing).

Reporting Person Kastelein Johannes Jacob Pieter · Officer Title Chief Scientific Officer · Transaction Code M

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001193125-26-412431 · filed 2026-10-02 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "NewAmsterdam Pharma Co N.V. (NAMS)." Disclosed 2026-10-02. https://desqlong.com/cards/0001193125-26-412431-1 (retrieved 2026-10-03).